DVAX vs. NIO

Last updated Apr 1, 2026

Compare and contrast key facts about Dynavax Technologies Corporation (DVAX) and NIO Inc. (NIO).

Performance

DVAX vs. NIO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Dynavax Technologies Corporation (DVAX) and NIO Inc. (NIO). The values are adjusted to include any dividend payments, if applicable.

DVAX vs. NIO - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018
DVAX Dynavax Technologies Corporation	0.78%	20.44%	-8.66%	31.39%	-24.38%	216.18%	-22.20%	-37.49%	-23.75%
NIO NIO Inc.	21.57%	16.97%	-51.93%	-6.97%	-69.22%	-35.00%	1,112.44%	-36.89%	-3.48%

Fundamentals

Market Cap DVAX : $2.12B NIO : $15.57B
EPS DVAX : -$0.32 NIO : -$6.45
PS Ratio DVAX : 6.44 NIO : 0.17
PB Ratio DVAX : 3.96 NIO : 3.74
Total Revenue (TTM) DVAX : $330.51M NIO : $87.01B
Gross Profit (TTM) DVAX : $274.90M NIO : $11.83B
EBITDA (TTM) DVAX : -$25.65M NIO : -$13.94B

Returns By Period

DVAX

• 1D: —
• 1M: —
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

NIO

• 1D: 2.82%
• 1M: 31.36%
• YTD: 21.57%
• 6M: -18.95%
• 1Y: 60.21%
• 3Y*: -16.13%
• 5Y*: -31.01%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

DVAX vs. NIO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NIO

NIO Risk / Return Rank: 69
NIO Sharpe Ratio Rank: 73
NIO Sortino Ratio Rank: 72
NIO Omega Ratio Rank: 65
NIO Calmar Ratio Rank: 69
NIO Martin Ratio Rank: 65

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

DVAX vs. NIO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Dynavax Technologies Corporation (DVAX) and NIO Inc. (NIO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

Sharpe Ratios by Period

	DVAX	NIO	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	—	0.97	—
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	-0.43	—
Sharpe Ratio (All Time) Calculated using the full available price history	—	-0.01	—

Correlation

The correlation between DVAX and NIO is 0.22, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

DVAX vs. NIO - Dividend Comparison

Neither DVAX nor NIO has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

Drawdown Indicators

	DVAX	NIO	Difference
Max Drawdown Largest peak-to-trough decline	—	-95.00%	—
Max Drawdown (1Y) Largest decline over 1 year	—	-43.73%	—
Max Drawdown (5Y) Largest decline over 5 years	—	-94.10%	—
Current Drawdown Current decline from peak	—	-90.13%	—
Average Drawdown Average peak-to-trough decline	—	-67.34%	—
Ulcer Index Depth and duration of drawdowns from previous peaks	—	23.26%	—

Volatility

Volatility by Period

	DVAX	NIO	Difference
Volatility (1M) Calculated over the trailing 1-month period	—	23.59%	—
Volatility (6M) Calculated over the trailing 6-month period	—	40.16%	—
Volatility (1Y) Calculated over the trailing 1-year period	—	62.29%	—
Volatility (5Y) Calculated over the trailing 5-year period, annualized	—	71.68%	—
Volatility (10Y) Calculated over the trailing 10-year period, annualized	—	87.25%	—

Financials

DVAX vs. NIO - Profitability Comparison

The chart below illustrates the profitability comparison between Dynavax Technologies Corporation and NIO Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

DVAX - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Dynavax Technologies Corporation reported a gross profit of 80.47M and revenue of 94.88M. Therefore, the gross margin over that period was 84.8%.

NIO - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, NIO Inc. reported a gross profit of 5.99B and revenue of 34.17B. Therefore, the gross margin over that period was 17.5%.

DVAX - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Dynavax Technologies Corporation reported an operating income of 21.27M and revenue of 94.88M, resulting in an operating margin of 22.4%.

NIO - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, NIO Inc. reported an operating income of 503.67M and revenue of 34.17B, resulting in an operating margin of 1.5%.

DVAX - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Dynavax Technologies Corporation reported a net income of 26.93M and revenue of 94.88M, resulting in a net margin of 28.4%.

NIO - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, NIO Inc. reported a net income of 280.15M and revenue of 34.17B, resulting in a net margin of 0.8%.